Letter: Primary amoebic meningoencephalitis.
D000562:Amebiasis / Q000188:drug therapy*; D000563:Amebicides / Q000494:pharmacology / Q000627:therapeutic use*; D000656:Amoeba / Q000187:drug effects; D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000008:administration & dosage; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D066298:In Vitro Techniques; D008590:Meningoencephalitis / Q000188:drug therapy*; D014320:Triphenylmethyl Compounds / Q000494:pharmacology / Q000627:therapeutic use
D000563:Amebicides; D000935:Antifungal Agents; D007093:Imidazoles; D014320:Triphenylmethyl Compounds; D000666:Amphotericin B